<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> is the third leading cause of <z:hpo ids='HP_0011420'>death</z:hpo> in the USA </plain></SENT>
<SENT sid="1" pm="."><plain>Antithrombotic therapy targeting platelet activation is one of the treatments for <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Here we investigate the role of one of the thrombin receptors, protease-activated receptor 4 (PAR4), in a mouse transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model </plain></SENT>
<SENT sid="3" pm="."><plain>After a 60 min MCAO and 23 h reperfusion, leukocyte and platelet rolling and <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> on cerebral venules, blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) permeability, and <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> were compared in PAR4-deficient mice and <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">Cerebral infarction</z:e> volume and neuronal <z:hpo ids='HP_0011420'>death</z:hpo> were also measured </plain></SENT>
<SENT sid="5" pm="."><plain>PAR4-/- mice had more than an 80% reduction of <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and significantly improved neurologic and motor function compared with <z:mp ids='MP_0002169'>wild-type</z:mp> mice after MCAO </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, deficiency of PAR4 significantly inhibits the rolling and <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of both platelets and leukocytes after MCAO </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="2" ids="33602">BBB</z:chebi> disruption and <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> were also attenuated in PAR4-/- mice compared with <z:mp ids='MP_0002169'>wild-type</z:mp> animals </plain></SENT>
<SENT sid="8" pm="."><plain>The results of this investigation indicate that deficiency of PAR4 protects mice from <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion (I/R) injury, partially through inhibition of platelet activation and attenuation of microvascular <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
</text></document>